Literature DB >> 2476271

Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation.

J W Gratama1, R A Langelaar, M A Oosterveer, J A van der Linden, A den Ouden-Noordermeer, A M Naipal, J W Visser, G C de Gast, H J Tanke.   

Abstract

A characteristic of active cytomegalovirus (CMV) infection is its suppressive effect on in vitro assays of immune function. The expression of CD11b by the Cd4+ and Cd8+ lymphocytes allows the identification of subsets with distinct regulatory functions of pokeweed mitogen (PWM) induced B cell differentiation. In order to relate that result with our previous observation that CMV carriers have significantly increased numbers of CD4+, HNK1+ and CD8+, HNK1+ lymphocytes in their peripheral blood compared with non-carriers, we performed a three-colour flow cytometric analysis of the co-expression of Cd11b and HNK1 by CD4+ and CD8+ lymphocytes obtained from 27 CMV carriers and 42 non-carriers. The differences between CMV carriers and non-carriers were significant for the CD4+, HNK1+ lymphocytes (median [5th and 95th percentiles], 59 [18 and 123 versus 24/7 and 73 per mm3, respectively; P less than 0.001) and CD8+, HNK1+ lymphocytes (59 [18 259] versus 52 [23 and 139] per mm3; P less than 0.001), but not for the CD4+, CD11b+ lymphocytes (59 [18 and 135] versus 52 [17 and 104] per mm3) and the CD8+, CD11b+ lymphocytes (85 [34 and 293] versus 82 [21 and 248] per mm3). The CD4+, HNK1+ and CD8+, HNK1+ lymphocytes that were increased in CMV carriers compared with non-carriers included mostly CD11b-, but also CD11b+ lymphocytes. After sorting CD4+ and CD8+ lymphocytes for four CMV carriers into HNK1+ and HNK1- fractions, we analyzed their regulatory functions on PWM-driven B cell Helper function to PWM-driven B cell differentiation was exclusively associated with the CD4+, HNK1- lymphocytes; the CD4+, HNK1+ generally did not show helper or suppressor activity in this assay. Both CD8+, HNK1+ and CD8+, HNK1- lymphocytes showed suppressor activity. Thus, the NHK1 marker does not constitute a phenotypical correlate for suppressor cells of PWM-driven B-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476271      PMCID: PMC1542001     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Functional studies on lymphocytes in adult human bone marrow. I. Immunoglobulin production in vitro after fractionation on a sucrose gradient and T/non-T cell separation.

Authors:  G C de Gast; T A Platts-Mills
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

2.  Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.

Authors:  A Landay; G L Gartland; L T Clement
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

3.  An interchangeable ELISA for cytomegalovirus antigen and antibody.

Authors:  V A Sundqvist; B Wahren
Journal:  J Virol Methods       Date:  1981-04       Impact factor: 2.014

4.  Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies.

Authors:  A W Ritchie; I Oswald; H S Micklem; J E Boyd; R A Elton; E Jazwinska; K James
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-04

5.  Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; V Iacoviello; M S Hirsch
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.

Authors:  M De Waele; C Thielemans; B K Van Camp
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

7.  Frequency and specificity of varicella zoster virus IgM response.

Authors:  V A Sundqvist
Journal:  J Virol Methods       Date:  1982-11       Impact factor: 2.014

8.  Flow cytometric and morphologic studies of HNK1+ (Leu 7+) lymphocytes in relation to cytomegalovirus carrier status.

Authors:  J W Gratama; H C Kluin-Nelemans; R A Langelaar; G J den Ottolander; T Stijnen; J D'Amaro; R Torensma; H J Tanke
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

9.  Comparison of complement-dependent cytotoxicity and indirect immunofluorescence for enumeration of T-cell subpopulations in human peripheral blood.

Authors:  J W Gratama; R K Schuurman; A Van Leeuwen; J Jansen; P Oljans; H J Tanke; J J Van Rood
Journal:  J Immunol Methods       Date:  1983-11-11       Impact factor: 2.303

10.  Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.

Authors:  T Abo; C A Miller; G L Gartland; C M Balch
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  4 in total

1.  B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence.

Authors:  Ramon Arens; Andrea Loewendorf; Min J Her; Kirsten Schneider-Ohrum; Geoffrey R Shellam; Edith Janssen; Carl F Ware; Stephen P Schoenberger; Chris A Benedict
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

2.  CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells.

Authors:  M Labalette; F Salez; F R Pruvot; C Noel; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

3.  Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses.

Authors:  E C Wang; J Taylor-Wiedeman; P Perera; J Fisher; L K Borysiewicz
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

4.  Proliferation and interleukin 5 production by CD8hi CD57+ T cells.

Authors:  Lee K Chong; Rebecca J Aicheler; Sian Llewellyn-Lacey; Peter Tomasec; Paul Brennan; Eddie C Y Wang
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.